CVS Health to Break Itself in Two, Spinning Off CVS Pharmacy

CVS Health will spin off its roughly 9,000-store retail pharmacy business as an independent, publicly traded CVS Pharmacy in the first half of 2028.

@sharedot

CVS Health to Break Itself in Two, Spinning Off CVS Pharmacy

By @sharedot · · 6 pages

  • Business
  • Retail
  • Healthcare
  • Corporate Restructuring

CVS Health will spin off its roughly 9,000-store retail pharmacy business as an independent, publicly traded CVS Pharmacy in the first half of 2028.

CVS undoes a decade of healthcare consolidation

CVS Health announced Wednesday that it will break itself into two publicly traded companies, separating its retail pharmacy business from the Aetna insurance unit and the Caremark prescription-benefits division.

The plan reverses the industry's long-running consolidation trend, which assembled vertically integrated giants that both Republicans and Democrats criticized when pharmacy executives testified in Congress earlier this year.

A breakup from a position of strength, not distress

The timing is the surprise: CVS is not a distressed seller.

CEO David Joyner, who will remain atop CVS Health, told analysts the company moved 'not out of a distressed decision,' pointing to a third quarter in which the company reported net income of $2.1 billion, an improvement over a nearly $4 billion loss a year earlier, according to Newsday.

CVS also raised its full-year profit outlook to at least $8.20 a share and projected at least $8.65 in adjusted 2027 earnings, per Transport Topics. Joyner argued that uncoupling retail, which 'has run somewhat independent of the enterprise,' will let it grow faster with dedicated investment.

Investors and economists see real risks

The market reacted sharply: Newsday reports that CVS shares fell 12.5% on Wednesday to $79.96 after the pre-market announcement, unwinding a company built through past acquisitions into a behemoth with significant influence over American healthcare spending.

Newsday also cites health economist John Rizzo of Stony Brook University, who warned that stand-alone drugstores lose the insurance profits behind them in 'the same industry that already put Rite Aid out of business,' making individual stores more vulnerable to closure.

RBC Capital Markets analyst Ben Hendrix, cited by Transport Topics, said the chain's long-term positioning in 'an already-challenged retail pharmacy environment will also warrant scrutiny.'

The stakes: scale, scrutiny and what stays behind

The scale of the two companies is enormous. Newsday reports the proposed CVS Health companies would generate about $320 billion in revenue this year, while the CVS Pharmacy entities would have roughly $145 billion.

Leadership splits accordingly: Joyner stays at CVS Health, and group president Prem Shah will run CVS Pharmacy.

The breakup does not fully answer lawmakers' concerns, Rizzo notes, because the benefits manager Caremark will remain under the same roof as CVS's specialty pharmacy business, which dispenses the most expensive drugs.

For now, both sides of the split will be publicly traded, and executives say the separated companies will have more flexibility to adopt new technology, adapt to regulation and pursue broader partnerships.

Sources

  1. ttnews.com › CVS Health plans retail pharmacy spinoff
  2. newsday.com › CVS Health plans to spin off pharmacies

More on Business